Suppr超能文献

胆管癌的流行病学、危险因素和发病机制。

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.

机构信息

Department of Hepatology and Gastroenterology, Imperial College London, London, UK.

出版信息

HPB (Oxford). 2008;10(2):77-82. doi: 10.1080/13651820801992641.

Abstract

Cholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within the liver (intrahepatic, ICC) or in the extrahepatic bile ducts (extrahepatic ECC). Globally, CCA is the second most common primary hepatic malignancy. Several recent epidemiological studies have shown that the incidence and mortality rates of ICC are increasing. This review of the literature on the international epidemiological rates of CCA, both intra- and extrahepatic, explores possible explanations for the trends found. The possible role of epidemiological artifact in the findings is discussed and the known risk factors for CCA are summarized. These include primary sclerosing cholangitis, liver fluke infestation, congenital fibropolycystic liver, bile duct adenomas, and biliary papillomatosis, hepatolithiasis, chemical carcinogens such as nitrosamines, Thorotrast, chronic viral hepatitis, cirrhosis, chronic non-alcoholic liver disease and obesity. Potential pathways involved in the molecular pathogenesis of CCA are also summarized.

摘要

胆管癌(CCA)是一种致命的胆管上皮癌,可发生在肝脏内(肝内 ICC)或肝外胆管(肝外 ECC)。在全球范围内,CCA 是第二常见的原发性肝恶性肿瘤。最近的几项流行病学研究表明,ICC 的发病率和死亡率正在上升。本文对国际上肝内和肝外 CCA 的流行病学发病率进行了文献综述,探讨了发现的趋势的可能解释。讨论了流行病学假象在研究结果中的可能作用,并总结了 CCA 的已知危险因素。这些危险因素包括原发性硬化性胆管炎、肝吸虫感染、先天性纤维多囊性肝病、胆管腺瘤和胆管乳头状瘤病、胆石症、化学致癌物如亚硝胺、Thorotrast、慢性病毒性肝炎、肝硬化、慢性非酒精性肝病和肥胖。还总结了 CCA 分子发病机制中涉及的潜在途径。

相似文献

1
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.
HPB (Oxford). 2008;10(2):77-82. doi: 10.1080/13651820801992641.
2
The epidemiology of cholangiocarcinoma.
Semin Liver Dis. 2004 May;24(2):115-25. doi: 10.1055/s-2004-828889.
3
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16.
4
New epidemiologic trends in cholangiocarcinoma.
Clin Res Hepatol Gastroenterol. 2023 Nov;47(9):102223. doi: 10.1016/j.clinre.2023.102223. Epub 2023 Oct 4.
5
Epidemiology of cholangiocarcinoma.
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16.
6
Precancerous lesions of intrahepatic cholangiocarcinoma.
J Hepatobiliary Pancreat Surg. 2000;7(6):542-50. doi: 10.1007/s005340070002.
7
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6.
9
Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14.
10
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.
World J Gastrointest Oncol. 2010 Nov 15;2(11):407-16. doi: 10.4251/wjgo.v2.i11.407.

引用本文的文献

5
Sonographic Predictors for Developing Cholangiocarcinoma: A Cohort Study from an Endemic Area.
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4229-4236. doi: 10.31557/APJCP.2024.25.12.4229.
6
Spatial analysis of cholangiocarcinoma in Thailand from 2012 to 2021; a population-based cancer registries study.
PLoS One. 2024 Dec 11;19(12):e0311035. doi: 10.1371/journal.pone.0311035. eCollection 2024.
7
Perihilar cholangiocarcinoma masquerading as intrahepatic cholestasis of pregnancy: a case report and review of the literature.
Front Med (Lausanne). 2024 Oct 23;11:1449865. doi: 10.3389/fmed.2024.1449865. eCollection 2024.
9
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma.
J Gastrointest Oncol. 2024 Aug 31;15(4):1777-1788. doi: 10.21037/jgo-24-165. Epub 2024 Aug 28.

本文引用的文献

1
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6.
2
Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
J Natl Cancer Inst. 2007 Jun 6;99(11):895-7. doi: 10.1093/jnci/djk201.
3
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23.
5
Cholangiocarcinoma: modern advances in understanding a deadly old disease.
J Hepatol. 2006 Dec;45(6):856-67. doi: 10.1016/j.jhep.2006.09.001. Epub 2006 Sep 25.
7
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203. doi: 10.1158/1055-9965.EPI-05-0811.
8
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
Br J Cancer. 2006 Jun 5;94(11):1751-8. doi: 10.1038/sj.bjc.6603127.
9
Cholangiocarcinoma.
Lancet. 2005 Oct 8;366(9493):1303-14. doi: 10.1016/S0140-6736(05)67530-7.
10
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
Gastroenterology. 2005 Mar;128(3):620-6. doi: 10.1053/j.gastro.2004.12.048.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验